INVO Fertility (IVF) Return on Capital Employed (2012 - 2026)
INVO Fertility's (IVF) quarterly Return on Capital Employed came in at 46.11% in Q1 2026, up 3338.0% year-on-year from 1.34% in Q1 2025, and up 51.2% on a QoQ basis from 94.49% in Q3 2025.
INVO Fertility (IVF) Return on Capital Employed (2012 - 2026) Analysis & Trends
INVO Fertility (IVF) has 15 years of Return on Capital Employed data on file, last reported at 46.11% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 3338.0% year-over-year to 46.11% in Q1 2026; TTM through Mar 2026 was 46.11%, a 3338.0% increase from a year earlier, with the FY2024 full-year figure at 55.84%, up 16211.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 46.11%, up from 94.49% in the prior quarter.
- Over the last five years, Return on Capital Employed for IVF reached as high as 460.17% in Q2 2023 and fell as low as 1635.9% in Q4 2022.
- Historically, Return on Capital Employed has averaged 119.06% across 5 years, with a median of 86.99% in 2025.
- Across the five-year window, Return on Capital Employed plunged 156820 bps in 2022 and surged 156663 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 1635.9% in 2022, then surged by 96 bps to 69.26% in 2023, then slumped by 120 bps to 152.72% in 2024, then soared by 38 bps to 94.49% in 2025, then surged by 51 bps to 46.11% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 46.11% in Q1 2026, 94.49% in Q3 2025, and 354.8% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | -46.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.11% |
| Sep 30, 2025 | -94.49% |
| Jun 30, 2025 | -354.80% |
| Mar 31, 2025 | -79.50% |
| Dec 31, 2024 | -152.72% |
| Sep 30, 2024 | 71.66% |
| Jun 30, 2024 | 262.50% |
| Mar 31, 2024 | -96.42% |
| Dec 31, 2023 | -69.26% |
| Sep 30, 2023 | -126.66% |
| Jun 30, 2023 | 460.17% |
| Mar 31, 2023 | 367.69% |
| Dec 31, 2022 | -1,635.90% |
| Sep 30, 2022 | -209.10% |
| Jun 30, 2022 | -122.79% |
| Mar 31, 2022 | -79.24% |
| Dec 31, 2021 | -67.69% |
| Sep 30, 2021 | -114.41% |
| Jun 30, 2021 | -79.32% |
| Mar 31, 2021 | -65.20% |